GlassScriptPhysician profile
Robert L Fontane
NPI 1033140637
$5,878.34
in general payments reported to CMS, 2019-2025
42 companies · $834 in 2025
The $834 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $854 · 2021: $879 · 2022: $641 · 2023: $680 · 2024: $1,014 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,429 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.76 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,251.92 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Endo Pharmaceuticals INC. | $597.19 | 2019-2024 | Xiaflex |
| Sumitomo Pharma America, INC. | $553.81 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $290.13 | 2019-2024 | |
| Abbvie INC. | $276.33 | 2019-2025 | |
| Antares Pharma, INC. | $275.14 | 2020-2022 | |
| Urogen Pharma, INC. | $239.09 | 2023-2025 | Jelmyto |
| Allergan, INC. | $211.71 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $209.68 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $200.27 | 2019-2025 | |
| Janssen Biotech, INC. | $175.85 | 2021-2025 | Erleada |
| Coloplast Corp | $140.19 | 2019-2024 | Speedicath |
| Ferring Pharmaceuticals INC. | $136.74 | 2019-2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $126.75 | 2021-2025 | Prolaris |
| Boston Scientific Corporation | $124.91 | 2019-2025 | General - Vascular Intervention, Lynx System |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fontane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.